News from actinium pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jan 08, 2014, 09:40 ET With Bone Marrow Transplants Rising, New Therapy Gives Hope to Those Over 55

 Bone marrow transplants are a $1.3 billion market and the fastest-growing hospital procedure in the U.S. They are the only potential cure for...


Dec 20, 2013, 08:35 ET Four Things to Ask Your Doctor About Bone Marrow Transplants

Those who have leukemia, lymphoma or other blood cancer diseases might have heard about bone marrow transplant as a potential treatment. As with...


Dec 09, 2013, 16:05 ET Actinium Pharmaceuticals to Present at the 24th Annual Oppenheimer Healthcare Conference

 Actinium Pharmaceuticals, Inc. (OTCQB: ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing  innovative targeted...


Dec 09, 2013, 07:00 ET Actinium Pharmaceuticals Announces Clinical Advisory Board Meeting At The 2013 ASH Conference

Actinium Pharmaceuticals, Inc. (OTCQB: ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload...


Dec 09, 2013, 06:00 ET Encouraging Clinical Data From Multicenter Phase 1/2 Trial On Actinium's Actimab-A Presented At American Society Of Hematology Annual Meeting

 Actinium Pharmaceuticals, Inc. (OTCQB: ATNM.OB) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted...


Dec 05, 2013, 07:00 ET Actinium Pharmaceuticals Presenting At The LD Micro Conference Today At 12:30 pm Pacific

Actinium Pharmaceuticals, Inc. (OTCQB: ATNM.OB) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload...


Dec 03, 2013, 07:00 ET Actinium Pharmaceutical's Announces Analyst Coverage

BURTON, Mich., Dec. 3, 2013 /PRNewswire/-- Actinium Pharmaceuticals, Inc. (OTCQB: ATNM) a pharmaceutical company developing drugs for...


Dec 03, 2013, 07:00 ET Actinium Pharmaceuticals Announces 2013 Annual Shareholder Meeting

 Actinium Pharmaceuticals, Inc. (OTCQB: ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload...


Dec 02, 2013, 07:00 ET Actinium Pharmaceuticals Announces Additional Clinical Data From Multicenter Phase 1/2 Trial on Actinium's Actimab-A to Be Presented at American Society of Hematology Annual Meeting

Actinium Pharmaceuticals, Inc. (OTCQB: ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload...


Nov 21, 2013, 07:00 ET Actinium Pharmaceuticals To Present At The LD Micro Conference

 Actinium Pharmaceuticals, Inc. (OTCQB: ATNM.OB) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted...


Nov 18, 2013, 07:00 ET Actinium Pharmaceuticals Announces Plans For Iomab™-B Phase 3 Pivotal Trial Following Meeting With FDA

 Actinium Pharmaceuticals, Inc. (OTCQB: ATNM.OB) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative, targeted...


Nov 12, 2013, 07:00 ET Actinium Pharmaceuticals Appoints Richard Steinhart As New Independent Director

Actinium Pharmaceuticals, Inc. (OTCQB: ATNM.OB) ("Actinium" or "the Company"), a biopharmaceutical Company developing  innovative targeted...


Nov 08, 2013, 07:00 ET Actinium Pharmaceuticals To Host Corporate Update And Virtual Roadshow Conference Call On November 11

Actinium Pharmaceuticals, Inc. (OTCQB: ATNM.OB) ("Actinium" or "the Company"), a biopharmaceutical Company developing  innovative targeted...


Oct 31, 2013, 06:30 ET Actinium Pharmaceuticals to Host Corporate Update and Virtual Roadshow Conference Call on November 11

Actinium Pharmaceuticals, Inc. (OTCQB: ATNM.OB) ("Actinium" or "the Company"), a biopharmaceutical Company developing  innovative targeted...


Oct 15, 2013, 07:00 ET Actinium Pharmaceuticals Webinar To Discuss Iomab™-B At 11AM EDT Today

 Actinium Pharmaceuticals, Inc. (OTCQB: ATNM.OB) ("Actinium" or "the Company"), a biopharmaceutical Company developing  innovative...


Oct 03, 2013, 16:04 ET Actinium Pharmaceuticals Announces Upcoming Webinar To Discuss Iomab™-B

 Actinium Pharmaceuticals, Inc. (OTCQB: ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing  innovative...


Sep 18, 2013, 06:00 ET Actinium Pharmaceuticals Appoints Corey Sohmer As Vice President Of Finance And Business Development

 Actinium Pharmaceuticals, Inc. (OTCQB: ATNM.OB) ("Actinium" or "the Company"), a biopharmaceutical Company developing  innovative...


Sep 16, 2013, 06:00 ET Actinium Pharmaceuticals Appoints Kaushik J. Dave, Ph.D., MBA As President, Chief Executive Officer And Director

 Actinium Pharmaceuticals, Inc. (OTCQB: ATNM.OB) ("Actinium" or "the Company"), a biopharmaceutical Company developing  innovative...


Jun 07, 2013, 07:00 ET Actinium Pharmaceuticals, Inc. Receives $3.5m from Exercise of Warrants

 Actinium Pharmaceuticals, Inc. (OTCQB: ATNM) announced today the recent issuance of 2,095,204 of its shares of common stock pursuant to the...


Jun 05, 2013, 07:00 ET Actinium Pharmaceuticals' Acute Myeloid Leukemia Clinical Data to be Presented Today at 8th International Symposium on Targeted Alpha Therapy Conference

Actinium Pharmaceuticals, Inc. (OTCBB: ATNM), a biopharmaceutical company that develops innovative targeted payload immunotherapeutics for...


May 16, 2013, 11:41 ET Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference

 Actinium Pharmaceuticals, Inc. (OTCBB: ATNM), a biopharmaceutical company that develops innovative targeted payload immunotherapeutics for...


May 13, 2013, 06:00 ET Actinium Pharmaceuticals, Inc. Receives Notice of Patent Allowance for a Key Application

 Actinium Pharmaceuticals, Inc. (OTCBB: ATNM), a biopharmaceutical company that develops innovative targeted payload immunotherapeutics for...


Apr 17, 2013, 14:00 ET Cactus Ventures, Inc. Changes Name to Actinium Pharmaceuticals, Inc.

 Cactus Ventures, Inc. (OTCBB: CTVN; OTCBB: ATNM), (the "Company") announced today that following the change of the Company's name from Cactus...


Feb 06, 2013, 15:27 ET Actinium Pharmaceuticals, Inc. To Present at the 15th Annual BIO CEO Investor Conference

 Actinium Pharmaceuticals, Inc. (OTC BB: CTVN) a biopharmaceutical company that develops innovative alpha particle immunotherapeutics, is...


Jan 28, 2013, 08:13 ET Actinium Pharmaceuticals to Present at EMIT Targeted Radiotherapy Conference

Actinium Pharmaceuticals, (OTC BB: CTVN), a biopharmaceutical company that develops innovative targeted payload immunotherapeutics, reported...